Literature DB >> 19147447

Cell therapy generates a favourable chemokine gradient for stem cell recruitment into the infarcted heart in rabbits.

Bai-Chin Lee1, Hsiu-Ching Hsu, Wen-Yih I Tseng, Ching-Yi Chen, Hung-Ju Lin, Yi-Lwun Ho, Ming-Jai Su, Ming-Fong Chen.   

Abstract

AIMS: Stem cell recruitment into the heart is determined by a concentration gradient of stromal-derived factor 1 (SDF-1) from bone marrow to peripheral blood and from blood to injured myocardium. However, this gradient is decreased in chronic myocardial infarction (MI). This study evaluated the effect of cell therapy using bone marrow stromal cells (BMSCs) on an SDF-1 gradient in post-infarction rabbits. METHODS AND
RESULTS: Myocardial infarction was induced in male New Zealand white rabbits (2.5-3 kg) by ligation of the left anterior descending coronary artery. Two months later, the rabbits were randomized to either saline or BMSC (2 x 10(6) autologous BMSCs injected into the left ventricular cavity) treatment. Four weeks after therapy, the SDF-1 gradients from bone marrow to blood and from blood to myocardium increased in the BMSC group compared with the saline group. This was accompanied by an increase in cells positive for CD34, CD117, and STRO-1 in the myocardium, resulting in more capillary density, better cardiac function, and a decrease in infarct size.
CONCLUSION: Generation of an SDF-1 gradient towards the heart is a novel effect of BMSC-based cell therapy. This effect facilitates stem cell recruitment into remodelled myocardium and supports improvement in cardiac function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19147447      PMCID: PMC2645052          DOI: 10.1093/eurjhf/hfn035

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  30 in total

1.  Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function.

Authors:  T Ponomaryov; A Peled; I Petit; R S Taichman; L Habler; J Sandbank; F Arenzana-Seisdedos; A Magerus; A Caruz; N Fujii; A Nagler; M Lahav; M Szyper-Kravitz; D Zipori; T Lapidot
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

2.  Normal systolic and diastolic functions of the left ventricle and left atrium by cine magnetic resonance imaging.

Authors:  Wen-Yih Isaac Tseng; Ta-Yu Liao; Jaw-Lin Wang
Journal:  J Cardiovasc Magn Reson       Date:  2002       Impact factor: 5.364

3.  Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not.

Authors:  Sarah A Wexler; Craig Donaldson; Patricia Denning-Kendall; Claire Rice; Ben Bradley; Jill M Hows
Journal:  Br J Haematol       Date:  2003-04       Impact factor: 6.998

4.  Migration of mesenchymal stem cells to heart allografts during chronic rejection.

Authors:  Gordon D Wu; Jan A Nolta; Yang-Sun Jin; Mark L Barr; Hong Yu; Vaughn A Starnes; Donald V Cramer
Journal:  Transplantation       Date:  2003-03-15       Impact factor: 4.939

5.  Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide.

Authors:  Jean-Pierre Lévesque; Jean Hendy; Yasushi Takamatsu; Paul J Simmons; Linda J Bendall
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

6.  CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow.

Authors:  Abraham Avigdor; Polina Goichberg; Shoham Shivtiel; Ayelet Dar; Amnon Peled; Sarit Samira; Orit Kollet; Rami Hershkoviz; Ronen Alon; Izhar Hardan; Herzl Ben-Hur; David Naor; Arnon Nagler; Tsvee Lapidot
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

7.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Authors:  Marc A Pfeffer; John J V McMurray; Eric J Velazquez; Jean-Lucien Rouleau; Lars Køber; Aldo P Maggioni; Scott D Solomon; Karl Swedberg; Frans Van de Werf; Harvey White; Jeffrey D Leimberger; Marc Henis; Susan Edwards; Steven Zelenkofske; Mary Ann Sellers; Robert M Califf
Journal:  N Engl J Med       Date:  2003-11-10       Impact factor: 91.245

8.  Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

Authors:  Arman T Askari; Samuel Unzek; Zoran B Popovic; Corey K Goldman; Farhad Forudi; Matthew Kiedrowski; Aleksandr Rovner; Stephen G Ellis; James D Thomas; Paul E DiCorleto; Eric J Topol; Marc S Penn
Journal:  Lancet       Date:  2003-08-30       Impact factor: 79.321

9.  Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction.

Authors:  Christian Valina; Kai Pinkernell; Yao-Hua Song; Xiaowen Bai; Sanga Sadat; Richard J Campeau; Thierry H Le Jemtel; Eckhard Alt
Journal:  Eur Heart J       Date:  2007-10-11       Impact factor: 29.983

10.  Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarction.

Authors:  Antonio Abbate; Rossana Bussani; Giuseppe G L Biondi-Zoccai; Raffaele Rossiello; Furio Silvestri; Feliciano Baldi; Luigi M Biasucci; Alfonso Baldi
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690

View more
  14 in total

1.  Bone marrow mesenchymal stem cell transplantation retards the natural senescence of rat hearts.

Authors:  Mingyu Zhang; Di Liu; Shuang Li; Lingling Chang; Yu Zhang; Ruixue Liu; Fei Sun; Wenqi Duan; Weijie Du; Yanping Wu; Tianyang Zhao; Chaoqian Xu; Yanjie Lu
Journal:  Stem Cells Transl Med       Date:  2015-04-08       Impact factor: 6.940

2.  Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells.

Authors:  Pearl Quijada; Haruhiro Toko; Kimberlee M Fischer; Brandi Bailey; Patrick Reilly; Kristin D Hunt; Natalie A Gude; Daniele Avitabile; Mark A Sussman
Journal:  Circ Res       Date:  2012-05-22       Impact factor: 17.367

3.  Composite scaffold provides a cell delivery platform for cardiovascular repair.

Authors:  Amandine F G Godier-Furnémont; Timothy P Martens; Michael S Koeckert; Leo Wan; Jonathan Parks; Kotaro Arai; Geping Zhang; Barry Hudson; Shunichi Homma; Gordana Vunjak-Novakovic
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-20       Impact factor: 11.205

4.  Progenitor Cells for the Treatment of Acute Myocardial Infarction.

Authors:  Benjamin J Herdrich; Robert C Gorman
Journal:  Adv Skin Wound Care       Date:  2010-01-01       Impact factor: 2.347

Review 5.  Emerging Trends in Mesenchymal Stem Cells Applications for Cardiac Regenerative Therapy: Current Status and Advances.

Authors:  Akriti Sharma; Santosh Gupta; S Archana; Rama Shanker Verma
Journal:  Stem Cell Rev Rep       Date:  2022-02-04       Impact factor: 5.739

6.  Sustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation.

Authors:  Pablo Maureira; Pierre-Yves Marie; Yihua Liu; Fengxu Yu; Sylvain Poussier; Fatiha Maskali; Frederique Groubatch; Gilles Karcher; Nguyen Tran
Journal:  Int J Cardiovasc Imaging       Date:  2013-02-13       Impact factor: 2.357

7.  Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap.

Authors:  Manuel Mazo; Miriam Araña; Beatriz Pelacho; Felipe Prosper
Journal:  Stem Cells Int       Date:  2012-01-22       Impact factor: 5.443

8.  Stroma cell-derived factor-1α signaling enhances calcium transients and beating frequency in rat neonatal cardiomyocytes.

Authors:  Ielham Hadad; Alex Veithen; Jean-Yves Springael; Panagiota A Sotiropoulou; Agnès Mendes Da Costa; Françoise Miot; Robert Naeije; Xavier De Deken; Kathleen Mc Entee
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

9.  A new method of wound treatment: targeted therapy of skin wounds with reactive oxygen species-responsive nanoparticles containing SDF-1α.

Authors:  Tao Tang; Hao Jiang; Yuan Yu; Fang He; Shi-zhao Ji; Ying-ying Liu; Zhong-shan Wang; Shi-chu Xiao; Cui Tang; Guang-Yi Wang; Zhao-Fan Xia
Journal:  Int J Nanomedicine       Date:  2015-10-19

10.  Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper Sampling.

Authors:  Lesley Baerts; Yannick Waumans; Inger Brandt; Wolfgang Jungraithmayr; Pieter Van der Veken; Marc Vanderheyden; Ingrid De Meester
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.